Generics 1

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Moxifloxacin manufacturers

1 products found

Filters

Filters

Filters , active

Country of origin : Oman

Clear all

1 products found

moxifloxacin

Tablets 400 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Oman
GMP approvals
Oman
Manufacturer #20765
It is one of the first pharmaceutical manufacturing companies in the Arabian Peninsula and has been in operation since the 2000s. The company has manufacturing operations in more than 3 countries covering oral solids, liquids, dry powders for reconstitution, and sachets covering various therapeutics like cardiovascular, antidiabetics, anti-infective, cough & cold, musculoskeletal, gastrointestinal, dermatology, central nervous system.

Manufacturer usually replies in 17 days

Moxifloxacin Manufacturers

Moxifloxacin is an antibiotic used to treat a range of bacterial infections, including but not limited to pneumonia, bronchitis, as well as abdominal, skin, and soft tissue infections. Moxifloxacin manufacturers produce it in the form of tablets, injectable solutions, and ophthalmic solutions. The developer and earliest moxifloxacin manufacturer were Bayer, who first acquired approval to market the drug in 1999. Currently, the drug has become approved in over 100 countries and has merited inclusion in the WHO’s list of Essential Medicines that contain the safest and most effective drugs recommended for a health system. Although Bayer still holds the largest share of the global moxifloxacin market, other manufacturers and suppliers have since introduced their formulations of the medication, with the largest of them being well-known multinational pharmaceutical companies such as Rivopharm, Actavis, Merck, and Allergan. Moxifloxacin suppliers and distributors market both generic and trade name formulations of the drug. Due to its efficacy, safety, and use around the world, the World Health Organization has put Moxifloxacin on the list of Essential and safe needed in a health system.

How Does Moxifloxacin Work?

The enzymes topoisomerase II (DNA gyrase) and topoisomerase IV are inhibited by moxifloxacin, which has a bactericidal effect. Active in the replication, replication, and repairing of bacterial DNA, DNA gyrase is a crucial enzyme. The splitting of the genetic Material during bacterial cell multiplication is known to be facilitated by the enzyme topoisomerase IV. A broad-spectrum antibiotic is a moxifloxacin. Both Gram-positive and Gram-negative bacteria are susceptible to its effects. It works by blocking topoisomerase IV and DNA gyrase, two enzymes required to split bacterial DNA. Cell replication is ultimately stopped as a result of this inhibition.

Wholesale Price of Moxifloxacin

The retail prices per 5 (400mg) tablets of moxifloxacin fall into an approximate range of 15,00 EUR to 25,00 EUR, whereas 5ml of the 5mg/ml ophthalmic moxifloxacin solution can cost anywhere from 5,00 EUR to 10,00 EUR. And 400mg/250ml moxifloxacin injectable solution is priced approximately at a range of 45,00 EUR to 65,00 EUR. Also, the costs of Moxifloxacin vary depending on manufacturer and supplier pricing, whether it is a generic or trade name formulation, concentration of the active ingredient in the formulation. Moxifloxacin suppliers, on the whole, are in favor of patient aid initiatives. Moxifloxacin is available for sale from various Moxifloxacin vendors at multiple costs.

From Where to Get Moxifloxacin?

Making use of Pipelinepharma's worldwide B2B online marketplace for medications and other pharmaceuticals is the ideal approach to locate and acquire access to moxifloxacin manufacturers and suppliers. Finding reliable suppliers and manufacturers of particular medications like Moxifloxacin can typically be a time-consuming challenge, but with Pipelinepharma's straightforward search engine and network of tested partners, the entire process becomes much simpler. Utilizing our built-in search engine, all you have to do to begin going is start looking for potential Moxifloxacin suppliers or manufacturers. You may also use filters to narrow down your search results and look for Moxifloxacin from particular nations.

Navigating our Pharmaceutical Marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Moxifloxacin offerings can be narrowed down with filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for this substance manufacturer and Moxifloxacin suppliers that you are looking for. These also enable you to check the dossier status of this medicine and the GMP approvals of the different variants of Moxifloxacin. Also, each manufacturer or supplier product description contains essential information about this substance, including clinical data, stability zones, and countries in which Moxifloxacin is already registered. Manufacturers also have special delivery terms.

Establishing Commercial Ties

Suppose you are a pharmaceutical licensing company or a distributor. In that case, you can enter into deals or negotiations over these medicine offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and order process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the Moxifloxacin suppliers. This way, the marketplace allows you as a distributor to skip the process of making a list of product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are boarded on the platform. This allows us to screen Moxifloxacin manufacturers for the quality of the pharmaceutical products' dossiers and protect against the risk of possible malpractices.